Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

J Hitti, PACTG P1022 Study Team, A Stek, C Hu, S K Burchett, B Best, E Smith, J S Read, H Watts, S Nachman, E M Thorpe Jr, S A Spector, E Jimenez, W T Shearer, M Foca, E V Capparelli, M Mirochnick, F Aweeka, PACTG 1026S Study Team. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Medicine. 2008. 9: 214-20. PMID: 18366444

Year

2008

Journal

HIV Medicine

Study

P1022, P1026S

Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy

Thomas C. Greenough, Coleen K. Cunningham, Petronella Muresan, Margaret McManus, Deborah Persaud, Terence Fenton, Piers Barker, Aditya Gaur, Dennis Panicali, John L. Sullivan, Katherine Luzuriaga. Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy. Vaccine. 2008. 26: 6883-93. PMID: 18940219

Year

2008

Journal

Vaccine

Study

P1059

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s

Francesca J. Torriani, Lauren Komarow, Robert A. Parker, Bruno R. Cotter, Judith Silverstein Currier, Michael P. Dube, Carl J. Fichtenbaum, Mariana Gerschenson, Carol K. Mitchell, Robert L. Murphy, Kathleen E. Squires, James H. Stein. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s. Journal of the American College of Cardiology. 2008. 52: 569-76.

Year

2008

Journal

Journal of the American College of Cardiology

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

Pablo Tebas, W. Keith Henry, Roy Matining, Deborah Weng-Cherng, John L. Schmitz, Hernan Valdez, Nasreen Jahed, Laurie S. Myers, William G. Powderly, David Katzenstein. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. Public Library of Science One. 2008. 3: 1-6.

Year

2008

Journal

Public Library of Science One

Class-sparing regimens for initial treatment of HIV-1 infection

John W. Mellors, Sharon A. Riddler, Richard H. Haubrich, Greg DiRienzo, Lynne Peeples, William G. Powderly, Karin L. Klingman, Kevin W. Garren, Tania George, James F. Rooney, Barbara Brizz, Umesh Gangharam Lalloo, Robert L. Murphy, Susan Swindells, Diane V. Havlir. Class-sparing regimens for initial treatment of HIV-1 infection. New England Journal of Medicine. 2008. 358: 2095-106.

Year

2008

Journal

New England Journal of Medicine

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts

Heather Ribaudo, Daniel R. Kuritzkes, Christina M. Lalama, Jeffrey T. Schouten, Bruce R. Schackman, Edward P. Acosta, Roy (Trip) Gulick. Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts. Journal of Infectious Diseases. 2008. 197: 1006-10.

Year

2008

Journal

Journal of Infectious Diseases

Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury

Constantin Yiannoutsos, Christos T. Nakas, Bradford A. Navia. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury. Neuroimage. 2008. 10: 248-55.

Year

2008

Journal

Neuroimage